FrancophonIA/ELRC3.0 huggingface dataset:
English: The animal should not be over-hydrated prior to administration.
Croatian: Životinja se ne smije pretjerano hidrirati prije primjene proizvoda.
English: CaC12 2H2O
Croatian: CaC12 2H2O NaOH
English: SPECIAL WARNING(S), IF NECESSARY
Croatian: POSEBNA UPOZORENJA, AKO JE POTREBNO
English: Do not microwave.
Croatian: Ne grijati u mikrovalnoj pećnici.
English: Do not use in animals previously treated with Oxyglobin.
Croatian: Ne primjenjivati na životinjama koje su prethodno liječene proizvodom Oxyglobin.
English: Shelf-life after first opening the immediate packaging: 24 hours.
Croatian: Rok valjanosti poslije prvog otvaranja unutarnjeg pakovanja: 24 sata.
English: Clinical Pathology
Croatian: Klinička patologija
English: Urinalysis: Sediment examination is accurate.
Croatian: Urinske pretrage: Ispitivanje sedimenta je točno.
English: Optical methods are not reliable for coagulation assays in the presence of Oxyglobin.
Croatian: Optičke metode nisu pouzdane za testove koagulacije u prisustvu proizvoda Oxyglobin.
English: Coagulation: Prothrombin time (PT) and activated partial thromboplastin time (aPTT) can be accurately determined using methods that are mechanical, magnetic, and light scattering.
Croatian: Koagulacija: Protrombinsko vrijeme (PT) i aktivno parcijalno tromboplastinsko vrijeme (aPTT) mogu se točno izmjeriti pomoću metoda kao što su mehaničko i magnetsko raspršenje ili raspršenje svjetla.
English: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Croatian: Bilo koji neupotrijebljeni veterinarsko-medicinski proizvod ili otpadni materijali dobiveni primjenom tih veterinarsko-medicinskih proizvoda moraju se odlagati u skladu s lokalnim propisima.
English: Pharmacotherapeutic group: Blood substitutes, ATCvet code: QB05AA10.
Croatian: Farmakoterapijska grupa: Zamjene za plazmu, ATCvet kod: QB05AA10.
English: Do not overheat.
Croatian: Ne pregrijavati.
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals
Croatian: Posebne mjere predostrožnost koje mora poduzeti osoba koja primjenjuje veterinarskomedicinski proizvod na životinjama
English: For a full list of excipients, see section 6.1.
Croatian: Pomoćne tvari: Potpuni popis pomoćnih tvari vidi u odjeljku 6.1.
English: The optimum dosage is based upon the degree and chronicity of the anaemia and the desired duration of the effect.
Croatian: Optimalna doza temelji se na stupnju i kroničnosti anemije i željenom trajanju utjecaja proizvoda.
English: Sodium lactate N-acetyl-l cysteine
Croatian: Natrijev laktat N-acetil-L cistein
English: Concomitant treatment of the cause of the anaemia should be instituted.
Croatian: Potrebno je provesti usporedno liječenje uzroka anemije.
English: * range based on mean ± SD ** range based on estimated mean value with bounds of a 95 % prediction interval *** range based on 5 terminal half-lives
Croatian: ± standardno odstupanje ** raspon temeljen na procijenjenoj srednjoj vrijednosti s granicama od 95% predviđenog intervala *** raspon temeljen na 5 krajnjih poluživota
English: Use within 24 hours of removing overwrap.
Croatian: Primijeniti u roku od 24 sata od uklanjanja pakovanja.
English: A small amount of unstabilised tetrameric haemoglobin (<5 %) may be excreted through the kidneys, resulting in transient haemoglobinuria for < 4 hours.
Croatian: Mala količina nestabiliziranog tetrameričkog hemoglobina (<5 %) može se izlučiti kroz bubrege, što rezultira prolaznom hemoglobinurijom u trajanju manjem od 4 sata.
English: Confirm that haemoglobin is measured, not calculated from red blood cell number.
Croatian: Potvrdite je li izmjeren hemoglobin i nije li računan od broja crvenih krvnih zrnaca.
English: Metabolism and excretion: Haemoglobin dissociates in plasma and is progressively incorporated in the protein pool of the organism.
Croatian: Metabolizam i izlučivanje: Hemoglobin se disocira u plazmu i progresivno inkorporira u proteinsku komponentu organizma.
English: THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable
Croatian: 13. RIJEČI “SAMO ZA PRIMJENU NA ŽIVOTINJAMA” I UVJETI ILI OGRANIČENJA U
English: Do not administer with other fluids or medicinal products concurrently via the same infusion set.
Croatian: Ne miješati s drugim tekućinama ili veterinarsko-medicinskim proizvodima u istom infuzijskom kompletu.
English: 4.4 Special warnings
Croatian: 4.4 Posebna upozorenja
English: Duration (hours): Oxyglobin levels over 1 g/dl**
Croatian: Trajanje (sati): Razine Oxyglobina preko 1 g/dl**
English: Adverse effects commonly seen were vomiting, a loss of appetite, and fever.
Croatian: Općenito primijećeni neželjeni događaji su bili povraćanje, gubitak apetita i groznica.
English: Signs of circulatory overload should be carefully monitored or central venous pressure (CVP) measured (increase in CVP has been recorded in all treated dogs in which it was measured).
Croatian: Potrebno je pažljivo nadgledati znakove preopterećenja kardiovaskularnog sustava ili centralni venski pritisak (porast centralnog venskog pritiska zabilježen je kod svih liječenih pasa kojima je on mjeren).
English: For animal treatment only - to be supplied only on veterinary prescription.
Croatian: Samo za primjenu na životinjama - izdaje se samo na veterinarski recept.
English: Remove overwrap prior to use.
Croatian: Uklonite omot prije primjene.
English: Oxyglobin is a haemoglobin-based oxygen carrying fluid that increases plasma and total haemoglobin concentrations and thus increases arterial oxygen content.
Croatian: Oxyglobin je tekućina koja prenosi kisik zasnovana na hemoglobinu koji povećava plazmu i ukupne koncentracije hemoglobina i tako povećava količinu kisika u arterijama.
English: THE WORDS “KEEP OUT OF THE REACH AND SIGHT OF CHILDREN”
Croatian: I POGLEDA DJECE” Čuvati izvan dosega i pogleda djece.
English: Do not add medications or other solutions to the bag.
Croatian: Ne dodavati druge veterinarsko-medicinske proizvode ili druge otopine u vrećicu.
English: 4.5 Special precautions for use Special precautions for use in animals
Croatian: 4.5 Posebne mjere predostrožnost za primjenu Posebne mjere predostrožnost za primjenu na životinjama
English: North Yorkshire, BD23 2RW United Kingdom
Croatian: North Yorkshire, BD23 2RW
English: Solution for infusion.
Croatian: Otopina za infuziju.
English: Treatment of circulatory overload may be necessary.
Croatian: Možda će biti potrebno liječenje preopterećenja kardiovaskularnog sustava.
English: As with any intravenous fluid administration, Oxyglobin should be warmed to 37 °C prior to administration.
Croatian: Kao i kod intravenske primjene tekućine, Oxyglobin je potrebno prije primjene zagrijati na 37 °C.
English: Excessive administration rate (>10 ml/kg/h) may result in circulatory overload.
Croatian: Prekomjerna brzina primjene (>10 ml/kg/h) može rezultirati preopterećenjem kardiovaskularnog sustava.
English: Immediate post infusion plasma concentration* (g/dl)
Croatian: Koncentracija u plazmi neposredno nakon infuzije* (g/dl)
English: Circulatory overload may be controlled by slowing the rate of administration.
Croatian: Preopterećenje kardiovaskularnog sustava može se kontrolirati smanjenjem brzine primjene.
English: Oxyglobin should be administered using aseptic technique via a standard intravenous infusion set and catheter.
Croatian: Oxyglobin se treba primijeniti uporabom aseptičnih tehnika pomoću standardnog kompleta za intravensku infuziju i katetera.
English: Overdosage or an excessive rate of administration (i.e., >10 ml/kg/h) could result in immediate cardiopulmonary effects, in which case infusion of Oxyglobin should be discontinued immediately until signs abate.
Croatian: Predoziranje ili prebrz ritam primjene (tj. >10 ml/kg/h) mogu rezultirati neposrednim kardiopulmonarnim učincima, u kojim slučajevima je potrebno obustaviti infuziju proizvoda Oxyglobin do smanjenja simptoma.
English: Marketing authorisation holder: OPK Biotech Netherlands BV Teleportboulevard 140
Croatian: Nositelj odobrenja za stavljanje u promet: OPK Biotech Netherlands BV Teleportboulevard 140
English: 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Croatian: 6.6 Posebne mjere predostrožnosti za odlaganje neupotrijebljenog veterinarsko-medicinskog proizvoda ili otpadnih materijala dobiveni primjenom tih proizvoda
English: MARKETING AUTHORISATION NUMBER
Croatian: BROJ ODOBRENJA ZA STAVLJANJE U PROMET
English: The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.
Croatian: Tiskana uputa o VMP mora sadržavati ime i adresu proizvođača odgovornog za otpuštanje odnosne serije.
English: The recommended dosage of Oxyglobin is 30 ml/kg of body weight administered intravenously at a rate up to 10 ml/kg/h.
Croatian: Preporučena doza proizvoda Oxyglobin je 30 ml/kg težine primijenjeno intravenozno brzinom do 10 ml/kg/h.
English: 125 ml infusion bag.
Croatian: Vrećica za infuziju od 125 ml.
English: D. STATEMENT OF THE MRLs
Croatian: IZVJEŠĆE O MRL
English: Use of Oxyglobin does not require typing or cross-matching of the recipient's blood.
Croatian: Primjena proizvoda Oxyglobin ne zahtijeva tipiziranje ili križnu probu primateljeve krvi.
English: Pharmacokinetic Parameters at Multiple Dose Levels after a Single Infusion of
Croatian: Farmakokinetički parametri pri razinama višestrukih doza nakon jedne infuzije proizvoda Oxyglobin
English: 60 ml infusion bag.
Croatian: Vrećica za infuziju od 60 ml.
English: (See Table A Pharmacokinetic Parameters)
Croatian: A Farmakokinetički parametri)
English: Plasma volume expanders, such as Oxyglobin, are contraindicated in dogs predisposed to circulatory overload with conditions such as oliguria or anuria or advanced cardiac disease (i.e., congestive heart failure) or otherwise severely impaired cardiac function.
Croatian: Ekspanderi volumena plazme, kao što je Oxyglobin kontraindicirani su na psima predisponiranim na preopterećenje kardiovaskularnog sustava sa stanjima kao što su oligurija, anurija ili uznapredovale srčane bolesti (npr. kongestivno zatajenje srca) ili druge teške srčane bolesti.
English: If CVP increases to a clinically unacceptable level and/or if signs of circulatory overload are observed, the infusion of Oxyglobin should be temporarily discontinued and re-instituted at a slower rate when signs abate and/or CVP decreases.
Croatian: Ako centralni venski pritisak naraste do nedopuštene razine i/ili su primijećeni znakovi preopterećenja kardiovaskularnog sustava, infuziju proizvoda Oxyglobin je potrebno privremeno obustaviti i ponovo primijeniti smanjenom brzinom nakon smanjenja simptoma i/ili smanjenja centralnog venskog pritiska.
English: Signs of circulatory overload should be carefully monitored or central venous pressure (CVP) measured.
Croatian: Potrebno je pažljivo nadgledati znakove preopterećenja kardiovaskularnog sustava ili centralni venski pritisak.
English: Occasionally noted effects were diarrhoea, discolouration of the skin, cardiac arrhythmias and very rarely nystagmus.
Croatian: Povremeno primijećeni štetni događaji su bili dijareja, dekoloracija kože, srčane aritmije i vrlo rijetko nistagmus.
English: Oxyglobin provides oxygen carrying support to dogs improving the clinical signs of anaemia for at least 24 hours, independent of the underlying condition.
Croatian: Oxyglobin pomaže u provođenju kisika psima, poboljšavajući kliničke znake anemije za vrijeme od najmanje 24 sata, neovisno o osnovnim uvjetima.
English: Table A: Pharmacokinetic Parameters at Multiple Dose Levels after a Single Infusion of Oxyglobin Dose (ml/kg)
Croatian: Tablica A: Farmakokinetički parametri pri razinama višestrukih doza nakon jedne infuzije Oxyglobina
English: Haeme degrades according to common pathways leading to bilirubin and bile pigments.
Croatian: Hem se razgrađuje u skladu s općim pravilima i pretvara se u bilirubin i žučne pigmente.
English: Effects commonly seen were vomiting, loss of appetite, fever, and circulatory overload with associated clinical signs such as tachypnea, dyspnea, harsh lung sounds, and pulmonary oedema; circulatory overload was controlled by slowing the rate of administration.
Croatian: Općenito primijećene nuspojave su bile povraćanje, gubitak apetita, groznica i preopterećenje kardiovaskularnog sustava s povezanim kliničkim znakovima kao što su tahipneja, dispneja, hrapav zvuk u plućima i plućni edem; preopterećenje kardiovaskularnog sustava je kontrolirano smanjenjem brzine primjene.
English: Adverse events related to Oxyglobin and/or the underlying disease causing anaemia have been observed.
Croatian: Primijećene su nuspojave povezane s proizvodom Oxyglobin i/ili osnovnom bolesti koja uzrokuje anemiju.
English: B. CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY OR USE
Croatian: UVJETI ILI OGRANIČENJA ODOBRENJA ZA STAVLJANJE U PROMET U
English: During the clinical safety and efficacy study, adverse events were seen which may have been related to Oxyglobin and/or the underlying disease causing anaemia.
Croatian: Za vrijeme ispitivanja neškodljivosti i djelotvornosti, primijećeni su štetni događaji povezani s proizvodom Oxyglobin i/ili osnovnom bolesti koja uzrokuje anemiju.
English: The safety and efficacy of Oxyglobin have not been evaluated in dogs with thrombocytopenia with active bleeding, oliguria or anuria, or advanced cardiac disease.
Croatian: Neškodljivost i djelotvornost proizvoda Oxyglobin nisu procijenjene kod pasa s trombocitopenijom s aktivnim krvarenjem, oligurijom ili anurijom ili uznapredovanom srčanom bolesti.
English: SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY
Croatian: 13. POSEBNE MJERE PREDOSTROŽNOSTI ZA ODLAGANJE NEUPOTRIJEBLJENOG PROIZVODA ILI OTPADNIH MATERIJALA, AKO IH IMA
English: A commonly observed undesirable effect was circulatory overload with associated clinical signs such as tachypnea, dyspnea, harsh lung sounds and pulmonary oedema.
Croatian: Uobičajeni primijećeni neželjeni događaji su bili preopterećenje kardiovaskularnog sustava s povezanim kliničkim znakovima kao što su tahipneja, dispneja, hrapav zvuk u plućima i plućni edem.
English: Occasionally noted adverse events were diarrhoea, cardiac arrhythmias and very rarely nystagmus.
Croatian: Povremeno primijećeni štetni događaji su bili dijareja, srčane aritmije i vrlo rijetko nistagma.
English: Hemoglobin glutamer-200 (bovine) - 130 mg/ml
Croatian: Hemoglobin glutamer-200 (goveđi) - 130 mg/ml
English: 39 Hurley Street
Croatian: Keighley Road
English: Oxyglobin is intended for single administration only.
Croatian: Oxyglobin je predviđen samo za jednokratnu primjenu.
English: Chemistry: The presence of Oxyglobin in serum may interfere with colorometric readings and result in artifactual increases or decreases in the results of serum chemistry tests depending on the dosage administered, the time since infusion, the type of analyzer and the reagents used.
Croatian: Kemija: Prisustvo proizvoda Oxyglobin u serumu može interferirati s kolorimetrijskim očitanjima i rezultatima umjetnog porasta ili smanjenja serumskih kemijskih pretraga ovisno o primijenjenoj dozi, vremenu proteklom od infuzije, vrsti analizatora i primijenjenim reagensima. (Kontaktirajte distributera za posebne podatke.)
English: The safety of Oxyglobin for use in pregnant or lactating bitches has not been determined.
Croatian: Neškodljivost proizvoda Oxyglobin nije utvrđena za vrijeme graviditeta ili laktacije ženki.
English: Haemoglobin glutamer-200 (bovine) - 130 mg/ml.
Croatian: Hemoglobin glutamer-200 (goveđi) - 130 mg/ml.
English: Oxyglobin 130 mg/ml solution for infusion for dogs
Croatian: Oxyglobin 130 mg/ml otopina za infuziju za pse
English: Oxyglobin is intended for single intravenous administration by infusion.
Croatian: Oxyglobin je predviđen samo za jednokratnu intravensku primjenu putem infuzije.
English: Oxyglobin Dose (ml/kg)
Croatian: Doza (ml/kg)
English: Special precautions for storage
Croatian: Posebne mjere predostrožnosti za čuvanje
English: Modified Lactated Ringer's Solution containing the standard components: Water for injection, NaCl
Croatian: 6.1 Popis pomoćnih tvari Modificirana Ringerova otopina koja sadrži uobičajene sastojke: Voda za injektiranje,
English: SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY
Croatian: 12. POSEBNE MJERE PREDOSTROŽNOSTI ZA ODLAGANJE NEUPOTRIJEBLJENIH PROIZVODA ILI OTPADNIH MATERIJALA, AKO IH IMA
English: Due to the plasma expanding properties of Oxyglobin, the possibility of circulatory overload and pulmonary oedema should be considered especially when administering adjunctive intravenous fluids, particularly colloidal solutions.
Croatian: Radi svojstava ekspandiranja plazme proizvoda Oxyglobin, potrebno je uzeti u obzir mogućnost preopterećenja kardiovaskularnog sustava i plućnog edema naročito kad se daju dodatne intravenske tekućine, a naročito koloidne otopine.
English: Due to the plasma expanding properties of Oxyglobin, the possibility of circulatory overload should be considered especially when administering adjunctive intravenous fluids, particularly colloidal solutions.
Croatian: Radi svojstava ekspandiranja plazme proizvoda Oxyglobin, potrebno je uzeti u obzir mogućnost preopterećenja kardiovaskularnog sustava osobito kad se daju dodatne intravenske tekućine, a naročito koloidne otopine.
English: Solution for infusion
Croatian: Otopina za infuziju
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
Croatian: IME I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE U PROMET I NOSITELJA ODOBRENJA ZA PROIZVODNJU ODGOVORNOG ZA OTPUŠTANJE
English: Undesirable effects include mild to moderate yellow/orange discoloration of the skin, mucous membranes, sclera, dark faeces and discoloured or turbid urine due to metabolism and/or excretion of haemoglobin.
Croatian: Neželjeni događaji uključuju blagu do umjerenu žuto-narančastu dekoloraciju kože, mukozne membrane, bjeloočnice, tamnu stolicu i dekoloraciju mutnog urina uzrokovanu metabolizmom i/ili izlučivanjem hemoglobina.
English: Dipstick measurements (i.e., pH, glucose, ketones, protein) are inaccurate while gross discolouration of the urine is present.
Croatian: Dok je prisutna značajna dekoloracija urina, ispitivanja metodom „dipstick“ (tj. pH, glukoza, ketoni, protein) su netočna.
English: PACKAGE LEAFLET: Oxyglobin 130 mg/ml solution for infusion for dogs
Croatian: UPUTA O VMP: Oxyglobin 130 mg/ml otopina za infuziju za pse
English: Side effects which were observed included mild to moderate discolouration of the mucous membranes, sclera, and urine due to metabolism and/or excretion of haemoglobin.
Croatian: Nuspojave koje su primijećene uključuju blagu do umjerenu dekoloraciju mukozne membrane, bjeloočnice i urina uzrokovani metabolizmom i/ili izlučivanjem hemoglobina.
English: 60 ml infusion bag 125 ml infusion bag
Croatian: VELIČINA PAKOVANJA Vrećica za infuziju od 60 ml Vrećica za infuziju od 125 ml
English: Manufacturer for the batch release: Dales Pharmaceutical Ltd. Snaygill Industrial Estate Keighley Road
Croatian: Snaygill Industrial Estate Keighley Road Skipton
English: Name and address of the manufacturer of the biological active substance OPK Biotech LLC
Croatian: Ime i adresa proizvođača biološki djelatne tvari
English: Cleared from plasma (days)***
Croatian: Klirens plazme (dana)***
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ BIOLOŠKI DJELATNE TVARI I NOSITELJ
English: Treatment with Oxyglobin results in a mild decrease in PCV (packed cell volume) immediately post infusion.
Croatian: Liječenje proizvodom Oxyglobin rezultira blagim padom hematokrita neposredno nakon infuzije.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE
Croatian: PODACI NA VANJSKOM PAKOVANJU PODACI NA UNUTARNJEM PAKOVANJU
English: NaOH
Croatian: NaCl
English: B. PACKAGE LEAFLET
Croatian: DODATAK II
English: The capsules should be given with food at around the same time each day.
Croatian: Kapsule treba uzimati s hranom u otprilike isto vrijeme svakog dana.
English: Ibrance is used in the following ways:
Croatian: Ibrance se primjenjuje na sljedeće načine:
English: Ibrance is available as capsules (75 mg, 100 mg and 125 mg).
Croatian: Ibrance je dostupan u obliku kapsula (od 75 mg, 100 mg i 125 mg).
English: The full EPAR for Ibrance can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Ibrance nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: In both studies, the main measure of effectiveness was how long patients lived without their disease getting worse (progression-free survival).
Croatian: U oba ispitivanja, glavna mjera djelotvornosti bila je dužina života bolesnica bez pogoršanja bolesti (preživljenje bez napredovanja bolesti).
English: The recommended dose is 125 mg once a day for 21 consecutive days, followed by a 7-day break to complete a 28-day treatment cycle.
Croatian: Preporučena doza je 125 mg jednom dnevno uzastopno tijekom 21 dana, a nakon toga slijedi 7 dana bez terapije čime je dovršen ciklus liječenja od 28 dana.
English: Regarding safety, the main risk is neutropenia, which is a well-known risk of many cancer medicines and is considered manageable.
Croatian: S obzirom na sigurnost, glavni rizik je neutropenija, a to je dobro poznati rizik kod primjene mnogih lijekova protiv raka i smatra se da ga se može kontrolirati.
English: What measures are being taken to ensure the safe and effective use of Ibrance?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Ibrance?
English: What is Ibrance and what is it used for?
Croatian: Što je Ibrance i za što se koristi?
English: If the patient experiences certain side effects, treatment may need to be interrupted or stopped, or the dose reduced.
Croatian: Ako bolesnica osjeti neke nuspojave, terapiju će možda trebati privremeno prekinuti ili zaustaviti ili smanjiti dozu.
English: It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use.
Croatian: Objašnjava kako je Agencija ocijenila lijek da bi preporučila njegovo odobrenje za stavljanje u promet u EU-u te uvjete za njegovu primjenu.
English: Treatment should continue for as long as the patient is benefitting from it and side effects are tolerable.
Croatian: Liječenje treba nastaviti sve dok bolesnica ima koristi od liječenja, a nuspojave su podnošljive.
English: Why is Ibrance approved?
Croatian: Zašto je Ibrance odobren?
English: Ibrance palbociclib
Croatian: Ibrance palbociklib
English: In women who have not yet reached menopause, a medicine called a luteinising hormone-releasing hormone agonist should also be given.
Croatian: U žena koje još nisu u menopauzi, potrebno je davati i lijek koji se naziva agonist hormona koji oslobađa luteinizirajući hormon.
English: • together with an aromatase inhibitor (a hormonal medicine for cancer);
Croatian: • u kombinaciji s inhibitorom aromataze (hormonskim lijekom protiv raka);
English: Other information about Ibrance
Croatian: Ostale informacije o lijeku Ibrance
English: Ibrance is a cancer medicine used to treat locally advanced or metastatic breast cancer (cancer that has begun to spread to other parts of the body).
Croatian: Ibrance je lijek protiv raka, a primjenjuje se za liječenje lokalno uznapredovalog ili metastatskog raka dojke (raka koji se počeo širiti na druge dijelove tijela).
English: This is a summary of the European public assessment report (EPAR) for Ibrance.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Ibrance.